查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1644034

醫療保健領域產生人工智慧的全球市場

Generative Artificial Intelligence in Healthcare
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球醫療保健領域生成人工智慧市場規模將達到 170 億美元

2024 年醫療保健領域生成人工智慧的全球市場規模估計為 27 億美元，預計到 2030 年將達到 170 億美元，在 2024-2030 年分析期內的複合年成長率為 36.0%。醫療保健生成式 AI 解決方案是該報告分析的細分市場之一，預計到分析期結束時複合年成長率將達到 34.6%，達到 97 億美元。預計在分析期間內，醫療保健產生 AI 服務領域的複合年成長率為 38.1%。

美國市場規模估計為 7.044 億美元，中國市場預計複合年成長率為 34.3%

預計 2024 年美國醫療保健領域的生成人工智慧市場價值將達到 7.044 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 25 億美元，2024-2030 年分析期間的複合年成長率為 34.3%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 32.7% 和 31.4%。在歐洲，德國的複合年成長率預計為 25.3%。

全球醫療保健市場中的生成人工智慧 - 主要趨勢和促進因素摘要

生成式人工智慧在醫療保健領域具有怎樣的變革潛力？

生成式AI透過分析複雜資料集和產生預測模型的能力再形成醫療保健，從而實現診斷、治療和患者照護的突破。透過利用大量患者資料、醫療記錄和影像掃描，人工智慧演算法可以提供準確、及時的見解，從而顯著改善臨床結果。生成式人工智慧能夠根據現有模式創建新資料，這在診斷成像方面特別有用，可以以無與倫比的準確度識別癌症、心臟病和神經系統疾病等疾病。除了診斷之外，該技術還將有助於建模複雜的生物系統，並能夠在電腦上模擬疾病進展和治療效果，減少對昂貴且耗時的物理實驗的依賴。個人化醫療已成為生成式人工智慧的主要應用。透過根據每個患者的基因和生活方式特徵來客製化治療方案，人工智慧可以提供最佳治療效果並將副作用降至最低。此外，該技術還透過模擬罕見和複雜的醫療狀況來支持醫學教育和培訓，使臨床醫生能夠在受控環境中磨練他們的技能。生成式人工智慧的這些變革能力已使其成為未來醫療保健服務的基石。

為什麼製藥業處於生成式人工智慧應用的前沿？

隨著生成式人工智慧加速藥物發現和開發，製藥業正模式轉移。這項技術大大減少了先前將新藥推向市場的高昂時間和成本。人工智慧主導的平台透過識別有前景的分子化合物、模擬它們的相互作用並預測其藥理特性來簡化臨床前階段。透過促進虛擬藥物測試和計算預測，生成性人工智慧最大限度地減少了後期失敗的可能性，確保了更高的成功率和更快的核准流程。事實證明，人工智慧在藥物再利用中所扮演的角色也將改變遊戲規則。透過分析現有資料並探索現有藥物的新用途，製藥公司可以有效解決未滿足的醫療需求。此外，生成性人工智慧將透過選擇最佳患者群體、確保遵守研究方案以及分析即時資料以識別異常來增強臨床試驗管理。這些創新不僅提高了藥物開發的速度和精確度，而且有助於提高成本效益並促進更重要的治療方法的更強大的管道。

醫療保健服務提供者如何將生成性人工智慧融入業務中？

醫院和醫療保健提供者正在採用生成性人工智慧來提高業務效率、患者照護和資源利用率。人工智慧系統正在徹底改變行政工作流程，從預約安排和計費到資料管理和合規性監控，使醫護人員能夠專注於直接與病患的互動。將人工智慧與電子健康記錄(EHR) 結合，使臨床醫生能夠獲得準確、最新的資訊，從而做出更快、更明智的決策。遠端醫療正在快速成長，部分原因是人工智慧虛擬助理和診斷工具的推動。這些平台透過提供即時洞察和監控能力提高了遠端諮詢的質量，尤其是在服務不足和農村地區。此外，人工智慧預測分析可以透過預測患者入院趨勢和最佳化人員部署來支援醫院資源規劃。由生成式人工智慧引導的機器人輔助手術在精確度方面樹立了新的標準並縮短了恢復時間。這些進步反映了人工智慧日益融入醫療保健生態系統，確保了醫療保健提供者和患者獲得更好的治療結果。

哪些因素推動了醫療保健市場生成式人工智慧的成長？

醫療保健市場中產生人工智慧的成長受到幾個關鍵因素的推動，例如醫療保健資料量的增加、計算能力的進步以及個人化護理的需求不斷成長。製藥公司採用人工智慧是重要的催化劑，可以加快藥物研發速度並降低成本。此外，遠端醫療服務和遠端醫療解決方案的擴展正在推動對人工智慧平台的需求，這些平台可以實現無縫、高效的患者管理，尤其是在醫療保健有限的地區。消費者對精準醫療和個人化治療的期望正在推動醫療保健提供者採用生成性 AI 工具，以提高患者滿意度和臨床結果。保險公司也開始使用人工智慧進行詐欺偵測、風險評估和個人化保險政策，該技術在醫療保健領域得到更廣泛的應用。此外，政府和私人實體正在大力投資人工智慧研究和創新，監管機構也在進行調整以確保合乎道德的部署和互通性。總的來說，這些因素凸顯了生成式人工智慧在醫療保健領域的變革性影響及其在塑造全球醫療保健系統未來方面的作用。

部分

組件（解決方案組件、服務組件）、功能（醫學影像分析功能、虛擬護理助理功能、機器人輔助AI手術功能、行政流程最佳化功能）、用途（臨床用途、系統用途）、最終用途（臨床研究最終用途、醫療中心最終用途、診斷中心最終用途、其他最終用途）

調查企業範例（共27家企業）

  • Amazon Web Services, Inc.
  • Deloitte
  • ELEKS
  • Google Cloud
  • IBM Corporation
  • Insilico Medicine
  • LeewayHertz
  • Microsoft Corporation
  • Nioyatech LLC
  • NVIDIA Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP31170

Global Generative Artificial Intelligence in Healthcare Market to Reach US$17.0 Billion by 2030

The global market for Generative Artificial Intelligence in Healthcare estimated at US$2.7 Billion in the year 2024, is expected to reach US$17.0 Billion by 2030, growing at a CAGR of 36.0% over the analysis period 2024-2030. Healthcare Generative AI Solutions, one of the segments analyzed in the report, is expected to record a 34.6% CAGR and reach US$9.7 Billion by the end of the analysis period. Growth in the Healthcare Generative AI Services segment is estimated at 38.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$704.4 Million While China is Forecast to Grow at 34.3% CAGR

The Generative Artificial Intelligence in Healthcare market in the U.S. is estimated at US$704.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 34.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.7% and 31.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 25.3% CAGR.

Global Generative Artificial Intelligence in Healthcare Market – Key Trends & Drivers Summarized

What Are the Transformative Capabilities of Generative AI in Healthcare?

Generative Artificial Intelligence is reshaping healthcare by leveraging its ability to analyze complex datasets and generate predictive models, enabling breakthroughs in diagnostics, treatment, and patient care. By harnessing vast volumes of patient data, medical records, and imaging scans, AI algorithms can deliver precise and timely insights that significantly enhance clinical outcomes. Generative AI's ability to create new data from existing patterns is particularly valuable in imaging diagnostics, where it identifies diseases such as cancer, heart conditions, and neurological disorders with unparalleled accuracy. Beyond diagnostics, the technology aids in modeling complex biological systems, allowing for the simulation of disease progression and treatment efficacy in silico, reducing the reliance on costly and time-intensive physical experiments. Personalized medicine has emerged as a flagship application of generative AI. By tailoring treatments to individual patients' genetic and lifestyle profiles, AI ensures optimized care with minimal adverse effects. Furthermore, the technology supports medical education and training by simulating rare and complex medical conditions, empowering clinicians to refine their skills in controlled environments. These transformative capabilities of generative AI have established it as a cornerstone of the future of healthcare delivery.

Why Is the Pharmaceutical Sector at the Forefront of Generative AI Adoption?

The pharmaceutical industry is experiencing a paradigm shift as generative AI accelerates drug discovery and development. This technology significantly reduces the traditionally prohibitive time and cost associated with bringing new drugs to market. AI-driven platforms identify promising molecular compounds, simulate their interactions, and predict pharmacological properties, streamlining the preclinical phase. By facilitating virtual drug trials and computational predictions, generative AI minimizes the likelihood of late-stage failures, ensuring higher success rates and faster approval processes. AI's role in drug repurposing has also proven to be a game-changer. By analyzing existing datasets and exploring new applications for established drugs, pharmaceutical companies can address unmet medical needs more efficiently. Furthermore, generative AI enhances clinical trial management by selecting optimal patient cohorts, ensuring adherence to study protocols, and analyzing real-time data to identify anomalies. These innovations not only improve the speed and accuracy of drug development but also contribute to cost-effectiveness, fostering more robust pipelines for critical therapies.

How Are Healthcare Providers Integrating Generative AI Into Operations?

Hospitals and healthcare providers are embracing generative AI to improve operational efficiency, patient care, and resource utilization. AI-powered systems are revolutionizing administrative workflows, from appointment scheduling and billing to data management and compliance monitoring, allowing healthcare staff to focus on direct patient interactions. Integrating AI with electronic health records (EHRs) ensures that clinicians have access to accurate, up-to-date information, enabling faster and more informed decision-making. Telemedicine has witnessed exponential growth, driven in part by AI-enabled virtual assistants and diagnostic tools. These platforms enhance the quality of remote consultations by offering real-time insights and monitoring capabilities, particularly in underserved and rural areas. Additionally, predictive analytics powered by AI supports hospitals in resource planning by forecasting patient admission trends and optimizing staff deployment. Robotic-assisted surgeries, guided by generative AI, are setting new benchmarks for precision and reducing recovery times. Together, these advancements reflect the growing integration of AI into healthcare ecosystems, ensuring improved outcomes for providers and patients alike.

What Factors Are Driving the Growth of the Generative AI in Healthcare Market?

The growth of the Generative Artificial Intelligence in Healthcare market is driven by several key factors, including the increasing volume of healthcare data, advancements in computational power, and the rising demand for personalized care. The adoption of AI by pharmaceutical companies has been a major catalyst, enabling faster drug discovery and reducing costs. Moreover, the expansion of telehealth services and remote care solutions has fueled demand for AI-powered platforms that facilitate seamless and efficient patient management, particularly in areas with limited healthcare access. Consumer expectations for precision medicine and tailored treatments have pushed healthcare providers to adopt generative AI tools that enhance patient satisfaction and clinical outcomes. Insurers are also turning to AI for fraud detection, risk assessment, and personalized policy creation, broadening the technology's application across the healthcare landscape. Additionally, governments and private entities are making significant investments in AI research and innovation, with regulatory bodies adapting to ensure ethical deployment and interoperability. These factors collectively underscore the transformative impact of generative AI on the healthcare sector and its role in shaping the future of global health systems.

SCOPE OF STUDY:

The report analyzes the Generative Artificial Intelligence in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Solutions Component, Services Component); Function (Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function, Administrative Process Optimization Function); Application (Clinical Application, System Application); End-Use (Clinical Research End-Use, Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 27 Featured) -

  • Amazon Web Services, Inc.
  • Deloitte
  • ELEKS
  • Google Cloud
  • IBM Corporation
  • Insilico Medicine
  • LeewayHertz
  • Microsoft Corporation
  • Nioyatech LLC
  • NVIDIA Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Generative Artificial Intelligence in Healthcare - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Generative AI Spurs Growth in Diagnostics and Personalized Healthcare Solutions
    • Expansion of Predictive Analytics Tools Broadens Addressable Market in Patient Care
    • Increased Demand for Virtual Health Assistants Drives AI Adoption in Telemedicine
    • Generative AI Revolutionizes Drug Discovery and Accelerates Development Timelines
    • Automation of Administrative Workflows Strengthens the Business Case for AI in Healthcare
    • AI-Driven Advances in Medical Imaging Propel Growth in Radiology Applications
    • IoMT Integration Sustains Growth Opportunities for AI in Connected Healthcare Systems
    • AI-Powered Clinical Decision Support Systems Propel Adoption Across Healthcare Facilities
    • Generative AI Addresses Workforce Shortages by Optimizing Healthcare Delivery
    • AI Innovations Enhance Market Potential for Mental Health Solutions
    • AI-Based Simulation Tools Drive Adoption in Medical Training and Education Programs
    • Precision Oncology Gains Momentum with Generative AI-Enabled Targeted Therapies
    • Data Privacy and Security Challenges Influence Market Dynamics and Adoption Rates
    • AI-Enhanced Patient Engagement Models Create New Opportunities in Care Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Generative Artificial Intelligence in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Solutions Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Medical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Clinical Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Medical Imaging Analysis Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Medical Imaging Analysis Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Virtual Nursing Assistants Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Virtual Nursing Assistants Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Robot-Assisted AI Surgery Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Robot-Assisted AI Surgery Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Administrative Process Optimization Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Administrative Process Optimization Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Clinical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Clinical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for System Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • JAPAN
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • CHINA
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • EUROPE
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • FRANCE
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • GERMANY
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Generative Artificial Intelligence in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by End-Use - Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by End-Use - Percentage Breakdown of Value Sales for Medical Centers End-Use, Diagnostic Centers End-Use, Other End-Uses and Clinical Research End-Use for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Function - Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Function - Percentage Breakdown of Value Sales for Medical Imaging Analysis Function, Virtual Nursing Assistants Function, Robot-Assisted AI Surgery Function and Administrative Process Optimization Function for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Generative Artificial Intelligence in Healthcare by Application - Clinical Application and System Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Generative Artificial Intelligence in Healthcare by Application - Percentage Breakdown of Value Sales for Clinical Application and System Application for the Years 2025 & 2030

IV. COMPETITION